Lp- PLA2 as a promising predictor of comorbidities in patients with severe psoriasis.
CONCLUSION: Lp-PLA2 assay might be helpful in assessment of the risk of cardiometabolic comorbidities development especially in patients with severe psoriasis and obesity.
PMID: 30998429 [PubMed - as supplied by publisher]
Source: Journal of Dermatological Treatment - Category: Dermatology Tags: J Dermatolog Treat Source Type: research
More News: Acitretin | Cardiology | Dermatology | Eating Disorders & Weight Management | Heart | Methotrexate | Obesity | Psoriasis | Skin | Statistics | Study